Last update : 07/22/2015 | Version : 2 | ID : 78
General | |
Identification | |
Detailed name | The Global Hypopituitary Control and Complications Study (HypoCCS)-A Global Observational Research Program |
Sign or acronym | HypoCCS |
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | CNIL N°903074 |
General Aspects | |
Medical area |
Endocrinology and metabolism |
Keywords | Somatotrope deficiency, adult, treatments, tolerance, quality of life |
Scientific investigator(s) (Contact) | |
Name of the director | Médecin pharmacoépidémiologiste |
pharmacoepi@lilly.com | |
Unit | Eli Lilly France |
Collaborations | |
Funding | |
Funding status |
Private |
Details | Eli Lilly and Company |
Governance of the database | |
Sponsor(s) or organisation(s) responsible | Eli Lilly |
Organisation status |
Private |
Additional contact | |
Main features | |
Type of database | |
Type of database |
Study databases |
Study databases (details) |
Longitudinal study (except cohorts) |
Database recruitment is carried out by an intermediary |
A selection of health institutions and services |
Database recruitment is is made on the basis of: |
Medication(s) taken |
Database recruitment is carried out as part of an interventional study |
No |
Additional information regarding sample selection. | Patients recruited by endocrinologists |
Database objective | |
Main objective | Primary objective: long-term follow-up of the clinical change and of the tolerance in patients with a somatotrope deficiency whether or not treated with somatropin (Umatrope®) |
Inclusion criteria |
- Adult patients suffering from growth hormone deficiency secondary to a hypothalamic or pituitary disease appearing in adulthood or suffering from a growth hormone deficiency since childhood,
- having terminated their growth (epiphyseal closure), - having no contraindications to the treatment such as are specified in the summary of product characteristics. |
Population type | |
Age |
Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) |
Population covered |
Sick population |
Gender |
Male Woman |
Geography area |
International |
Detail of the geography area | international |
Data collection | |
Dates | |
Date of first collection (YYYY or MM/YYYY) | 2003 |
Date of last collection (YYYY or MM/YYYY) | 2013 |
Size of the database | |
Size of the database (number of individuals) |
[1000-10 000[ individuals |
Details of the number of individuals | recruitment closed |
Data | |
Database activity |
Data collection completed |
Type of data collected |
Clinical data Declarative data Paraclinical data Biological data |
Clinical data (detail) |
Direct physical measures Medical registration |
Declarative data (detail) |
Paper self-questionnaire |
Paraclinical data (detail) | ECG, MRI, Scanner (if available) |
Biological data (detail) | IGF-I, lipidic and glycemic profile, hormone assays (if available) |
Presence of a biobank |
No |
Health parameters studied |
Health event/morbidity Quality of life/health perception |
Procedures | |
Data collection method | Data collection notebook and questionnaire |
Participant monitoring |
Yes |
Details on monitoring of participants | Followed for 10 to 10 years according to the date of inclusion |
Links to administrative sources |
No |
Promotion and access | |
Promotion | |
Link to the document | http://tinyurl.com/Pubmed-HYPOCCS |
Description | List of publications in Pubmed |
Access | |
Terms of data access (charter for data provision, format of data, availability delay) | Report and publication |
Access to aggregated data |
Access on specific project only |
Access to individual data |
Access on specific project only |
Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05